| BerlinRosen | 72.1 | 5 | 2 |
| Online PR Agency Platform | 69.1 | 3 | 3 |
| Kinsta | 60.0 | 10 | 0 |
| Hill & Knowlton | 54.8 | 2 | 2 |
| Edelman | 51.9 | 3 | 1 |
| Brunswick Review | 44.8 | 5 | 0 |
| Ogilvy | 44.7 | 2 | 1 |
| Golin Harris International | 44.7 | 2 | 1 |
| Ruder Finn | 44.7 | 2 | 1 |
| Cision | 44.7 | 2 | 1 |
| WE Communications | 44.7 | 2 | 1 |
| Burson | 44.6 | 1 | 2 |
| American Automobile Association | 40.0 | 0 | 4 |
| SVB Private | 34.7 | 3 | 0 |
| Havas | 34.6 | 1 | 1 |
| WPP plc | 34.6 | 1 | 1 |
| Ketchum Inc. | 34.6 | 1 | 1 |
| MSLGROUP | 34.6 | 1 | 1 |
| 5W Public Relations | 34.6 | 1 | 1 |
| PRWeek | 34.6 | 1 | 1 |
| Sparkpr | 34.6 | 1 | 1 |
| MikeWorldWide | 34.6 | 1 | 1 |
| Jonathan Rosen | 34.6 | 1 | 1 |
| Finsbury Glover Hering | 34.6 | 1 | 1 |
| Brunswick Group | 34.6 | 1 | 1 |
| PRLab | 34.6 | 1 | 1 |
| PR Platform | 34.5 | 0 | 3 |
| Apple Inc. | 27.5 | 2 | 0 |
| Lazard | 27.5 | 2 | 0 |
| Weber Shandwick | 27.5 | 2 | 0 |
| Robert Half | 27.5 | 2 | 0 |
| FGS Global | 27.5 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 27.5 | 2 | 0 |
| bidirectional encoder representations from transformers | 27.5 | 2 | 0 |
| R & D Directions | 27.5 | 2 | 0 |
| SVB Financial Group | 27.5 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 27.5 | 2 | 0 |
| public relations | 27.3 | 0 | 2 |
| press release | 27.3 | 0 | 2 |
| Tux Paint | 27.3 | 0 | 2 |
| United States Department of Agriculture | 27.3 | 0 | 2 |
| Institution of Engineering and Technology | 27.3 | 0 | 2 |
| media relations | 27.3 | 0 | 2 |
| James E. Grunig | 27.3 | 0 | 2 |
| Luther Pendragon | 27.3 | 0 | 2 |
| Policy by press release | 27.3 | 0 | 2 |
| Public Relations Journal | 27.3 | 0 | 2 |
| Public Relations Review | 27.3 | 0 | 2 |
| Richard Edelman | 27.3 | 0 | 2 |
| SKDKnickerbocker | 27.3 | 0 | 2 |
| press release magazine | 27.3 | 0 | 2 |
| public relations agency | 27.3 | 0 | 2 |
| 2003 Wikipedia Press Release | 27.3 | 0 | 2 |
| Crisis Communications Management on the Web: How Internet-Based Technologies are Changing the Way Public Relations Professionals Handle Business Crises | 27.3 | 0 | 2 |
| The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals | 27.3 | 0 | 2 |
| There's more to public relations than press releases | 27.3 | 0 | 2 |
| Media Catching and the Journalist–Public Relations Practitioner Relationship: How Social Media are Changing the Practice of Media Relations | 27.3 | 0 | 2 |
| Press Releases and Other Records Useful for Public Relations (NAID 2107195) | 27.3 | 0 | 2 |
| Collection of the Canadian Union of Public Employees, National Office, Public Relations Department | 27.3 | 0 | 2 |
| Public Relations Set, Press Releases (NAID 6851554) | 27.3 | 0 | 2 |
| Public Relations Section Press Releases (NAID 5889956) | 27.3 | 0 | 2 |
| Building a new or better image for your practice through solid media relations (public relations and publicity) | 27.3 | 0 | 2 |
| Good publication practice guidelines for medical communications agencies: a MedComm perspective | 27.3 | 0 | 2 |
| Comment on: Good publication practice guidelines for medical communications agencies: a MedComm perspective | 27.3 | 0 | 2 |
| Scars: Clinical Evidence Base and Patient Impact | 27.3 | 0 | 2 |
| A methodological approach to assessing the quality of medical health information on its way from science to the mass media | 27.3 | 0 | 2 |
| OMD Worldwide | 27.3 | 0 | 2 |
| PR Nigeria | 27.3 | 0 | 2 |
| Press Releases | 27.3 | 0 | 2 |
| [Letter on the Subject of the Staffing of Public Relation Departments with Particular Reference to the Appointment of Officers to Take Charge of the Departments] | 27.3 | 0 | 2 |
| Sean Spicer is the News: The Relationship Between Sean Spicer and The White House Press Corps | 27.3 | 0 | 2 |
| Contemporary Media Relations: Potential of Twitter in Mediating Relationships Between Public Relations Practitioners and Journalists in New Zealand | 27.3 | 0 | 2 |
| PRWeb | 27.3 | 0 | 2 |
| Research on the Positive Public Relations Practice of Local Government Press Release in Response to Public Emergencies——A Case Study of Guangdong Governmental Press Conferences on COVID-19 Epidemic Prevention and Control in 2020 | 27.3 | 0 | 2 |
| Krishnamurthy Sriramesh | 27.3 | 0 | 2 |
| Overcoming the Next Crisis: Media Relations and Crisis Communications in Forensic Science | 27.3 | 0 | 2 |
| Q130038854 | 27.3 | 0 | 2 |
| MANAGING RESTAURANTS CRISIS COMMUNICATIONS: THE ROLE OF PUBLIC RELATIONS | 27.3 | 0 | 2 |
| Public Relations Strategy Analysis Crisis Communications | 27.3 | 0 | 2 |
| MSL | 27.3 | 0 | 2 |
| Matt de Nesnera | 27.3 | 0 | 2 |
| Amy Lynn | 27.3 | 0 | 2 |
| Oui Speak Fashion | 27.3 | 0 | 2 |
| Energy PR | 27.3 | 0 | 2 |
| Q140008282 | 27.3 | 0 | 2 |
| Executive Presence | 27.3 | 0 | 2 |
| .Mac | 17.3 | 1 | 0 |
| arXiv | 17.3 | 1 | 0 |
| GfK | 17.3 | 1 | 0 |
| Cision | 17.3 | 1 | 0 |
| Octagon | 17.3 | 1 | 0 |
| Fleishman-Hillard | 17.3 | 1 | 0 |
| Weber-Stephen Products | 17.3 | 1 | 0 |
| Manatt, Phelps & Phillips | 17.3 | 1 | 0 |
| APCO | 17.3 | 1 | 0 |
| Boy Genius Report | 17.3 | 1 | 0 |
| FTI Consulting | 17.3 | 1 | 0 |
| Fahlgren Mortine | 17.3 | 1 | 0 |
| Guidehouse | 17.3 | 1 | 0 |
| Science Media Centre | 17.3 | 1 | 0 |
| Teneo | 17.3 | 1 | 0 |
| Wilson Sonsini Goodrich & Rosati | 17.3 | 1 | 0 |
| Blue Fountain Media | 17.3 | 1 | 0 |
| CCgroup | 17.3 | 1 | 0 |
| Apptio | 17.3 | 1 | 0 |
| J. R. O'Dwyer Company | 17.3 | 1 | 0 |
| Shift Communications | 17.3 | 1 | 0 |
| Silicon Valley Bank | 17.3 | 1 | 0 |
| Syneos Health | 17.3 | 1 | 0 |
| Rock Health | 17.3 | 1 | 0 |
| FTI Consulting EMEA | 17.3 | 1 | 0 |
| FTI Consulting LATAM | 17.3 | 1 | 0 |
| FTI Consulting APAC | 17.3 | 1 | 0 |
| LBMC | 17.3 | 1 | 0 |
| Kelly L. Weinersmith | 17.3 | 1 | 0 |
| Axon (United States) | 17.3 | 1 | 0 |
| Wikimedia Foundation | 17.2 | 0 | 1 |
| Bihar | 17.2 | 0 | 1 |
| Michael Schmidt-Salomon | 17.2 | 0 | 1 |
| Deborah Estrin | 17.2 | 0 | 1 |
| Jimmy Carter | 17.2 | 0 | 1 |
| IUCN Red List | 17.2 | 0 | 1 |
| marketing | 17.2 | 0 | 1 |
| Common Desktop Environment | 17.2 | 0 | 1 |
| ABB Group | 17.2 | 0 | 1 |
| General Electric | 17.2 | 0 | 1 |
| Jean-Claude Juncker | 17.2 | 0 | 1 |
| Q62233 | 17.2 | 0 | 1 |
| General Motors | 17.2 | 0 | 1 |
| Noga Alon | 17.2 | 0 | 1 |
| Günter Bentele | 17.2 | 0 | 1 |
| Paul Lauterbur | 17.2 | 0 | 1 |
| Portuguese Timor | 17.2 | 0 | 1 |
| Q163628 | 17.2 | 0 | 1 |
| Ems dispatch | 17.2 | 0 | 1 |
| Q171477 | 17.2 | 0 | 1 |
| KLM | 17.2 | 0 | 1 |
| Charles Hard Townes | 17.2 | 0 | 1 |
| Martha Stewart | 17.2 | 0 | 1 |
| Pasilalinic-sympathetic compass | 17.2 | 0 | 1 |
| BRICS | 17.2 | 0 | 1 |
| Edwin T. Meredith | 17.2 | 0 | 1 |
| Sprint Corporation | 17.2 | 0 | 1 |
| Adel Massaad | 17.2 | 0 | 1 |
| Bengt Holmström | 17.2 | 0 | 1 |
| Virgin Galactic | 17.2 | 0 | 1 |
| PR Newswire | 17.2 | 0 | 1 |
| crisis communication | 17.2 | 0 | 1 |
| Air India Express Flight 812 | 17.2 | 0 | 1 |
| Oliver Hart | 17.2 | 0 | 1 |
| Edward Bernays | 17.2 | 0 | 1 |
| María Corina Machado | 17.2 | 0 | 1 |
| Jon Fosse | 17.2 | 0 | 1 |
| press kit | 17.2 | 0 | 1 |
| Alyeska Pipeline Service Company | 17.2 | 0 | 1 |
| Q461631 | 17.2 | 0 | 1 |
| American Medical Association | 17.2 | 0 | 1 |
| American Petroleum Institute | 17.2 | 0 | 1 |
| Propaganda | 17.2 | 0 | 1 |
| Roy Thomas Baker | 17.2 | 0 | 1 |
| Ansgar Zerfaß | 17.2 | 0 | 1 |
| SourceWatch | 17.2 | 0 | 1 |
| United States Department of Labor | 17.2 | 0 | 1 |
| Q636192 | 17.2 | 0 | 1 |
| Enel | 17.2 | 0 | 1 |
| Fluor Corporation | 17.2 | 0 | 1 |
| Bell Pottinger Private | 17.2 | 0 | 1 |
| hard science fiction | 17.2 | 0 | 1 |
| Mount Vernon | 17.2 | 0 | 1 |
| National Air and Space Museum | 17.2 | 0 | 1 |
| August Heinrichsbauer | 17.2 | 0 | 1 |
| Biola University | 17.2 | 0 | 1 |
| Gedore | 17.2 | 0 | 1 |
| Hidenao Nakagawa | 17.2 | 0 | 1 |
| Nasher Sculpture Center | 17.2 | 0 | 1 |
| electronic press kit | 17.2 | 0 | 1 |
| Ehud Hrushovski | 17.2 | 0 | 1 |
| litigation public relations | 17.2 | 0 | 1 |
| John Joseph O'Connor | 17.2 | 0 | 1 |
| Ferenc Heves | 17.2 | 0 | 1 |
| The 3DO Company | 17.2 | 0 | 1 |
| CERP – European Confederation of Public Relations | 17.2 | 0 | 1 |
| Dentsu | 17.2 | 0 | 1 |
| Denver Art Museum | 17.2 | 0 | 1 |
| Deutsche Akademie für Public Relations | 17.2 | 0 | 1 |
| Deutsche Public-Relations-Gesellschaft | 17.2 | 0 | 1 |
| Deutscher Rat für Public Relations | 17.2 | 0 | 1 |
| Deutsches Institut für Altersvorsorge | 17.2 | 0 | 1 |
| Human Rights Campaign | 17.2 | 0 | 1 |
| Q1274535 | 17.2 | 0 | 1 |
| Public Relations | 17.2 | 0 | 1 |
| media monitoring service | 17.2 | 0 | 1 |
| publicity | 17.2 | 0 | 1 |
| Ivy Lee | 17.2 | 0 | 1 |
| Fritz Nathan | 17.2 | 0 | 1 |
| halotherapy | 17.2 | 0 | 1 |
| General Association of Communications Agencies | 17.2 | 0 | 1 |
| Q1518346 | 17.2 | 0 | 1 |
| Publicis | 17.2 | 0 | 1 |
| Green Bank Telescope | 17.2 | 0 | 1 |
| 100 patriotic songs | 17.2 | 0 | 1 |
| mc Group | 17.2 | 0 | 1 |
| Java platform | 17.2 | 0 | 1 |
| United States Southern Command | 17.2 | 0 | 1 |
| public diplomacy | 17.2 | 0 | 1 |
| Austrian State Prize | 17.2 | 0 | 1 |
| Michael W. Young | 17.2 | 0 | 1 |
| organizational communication | 17.2 | 0 | 1 |
| news aktuell | 17.2 | 0 | 1 |
| Japan Confederation of A- and H-Bomb Sufferers Organizations | 17.2 | 0 | 1 |
| State Farm Insurance | 17.2 | 0 | 1 |
| WiiWare | 17.2 | 0 | 1 |
| public relations research | 17.2 | 0 | 1 |
| Peter Schiwy | 17.2 | 0 | 1 |
| press office | 17.2 | 0 | 1 |
| Q2116348 | 17.2 | 0 | 1 |
| Rainer Gerlach | 17.2 | 0 | 1 |
| Rudolf F. Thomas | 17.2 | 0 | 1 |
| Abba Seraphim | 17.2 | 0 | 1 |
| Stephen Tallents | 17.2 | 0 | 1 |
| Timothy Bell, Baron Bell | 17.2 | 0 | 1 |
| Maja Ivarsson | 17.2 | 0 | 1 |
| Albert Oeckl | 17.2 | 0 | 1 |
| Seven Kingdoms II: The Fryhtan Wars | 17.2 | 0 | 1 |
| Presidential state car | 17.2 | 0 | 1 |
| White House Communications Agency | 17.2 | 0 | 1 |
| Benador Associates | 17.2 | 0 | 1 |
| communications manager | 17.2 | 0 | 1 |
| influencer communications agency | 17.2 | 0 | 1 |
| Q3100429 | 17.2 | 0 | 1 |
| CNW Group | 17.2 | 0 | 1 |
| James Hoggan | 17.2 | 0 | 1 |
| Daniel Edelman | 17.2 | 0 | 1 |
| Chief William Commanda Bridge | 17.2 | 0 | 1 |
| Publicis Healthcare Communications Group | 17.2 | 0 | 1 |
| Sam Pitroda | 17.2 | 0 | 1 |
| Tony Blankley | 17.2 | 0 | 1 |
| history of public relations | 17.2 | 0 | 1 |
| public relations officer | 17.2 | 0 | 1 |
| Gordon Johndroe | 17.2 | 0 | 1 |
| Karun Treasure | 17.2 | 0 | 1 |
| publicist | 17.2 | 0 | 1 |
| Communications Authority of Kenya | 17.2 | 0 | 1 |
| People's Commissariat for Communications of the USSR | 17.2 | 0 | 1 |
| Resurs-P No.1 | 17.2 | 0 | 1 |
| Federal Communications Agency (Russia) | 17.2 | 0 | 1 |
| churnalism | 17.2 | 0 | 1 |
| A Frank Statement to Cigarette Smokers | 17.2 | 0 | 1 |
| Adrian Bevington | 17.2 | 0 | 1 |
| American Public Relations Forum | 17.2 | 0 | 1 |
| Anna Siewierska | 17.2 | 0 | 1 |
| Anthony Bailey | 17.2 | 0 | 1 |
| Anthony Mora | 17.2 | 0 | 1 |
| Helen Dean King | 17.2 | 0 | 1 |
| Arthur W. Page | 17.2 | 0 | 1 |
| Asia Pacific Public Relations Journal | 17.2 | 0 | 1 |
| Benjamin Wegg-Prosser | 17.2 | 0 | 1 |
| Berman and Company | 17.2 | 0 | 1 |
| Beth McRae | 17.2 | 0 | 1 |
| Blausen Medical | 17.2 | 0 | 1 |
| Bob Ward | 17.2 | 0 | 1 |
| Boneau/Bryan-Brown | 17.2 | 0 | 1 |
| Bozell | 17.2 | 0 | 1 |
| Božo Skoko | 17.2 | 0 | 1 |
| Brown Lloyd James | 17.2 | 0 | 1 |
| Capitol Campaign Strategies | 17.2 | 0 | 1 |
| Carilion Clinic | 17.2 | 0 | 1 |
| Carr Communications | 17.2 | 0 | 1 |
| Central Office of Information | 17.2 | 0 | 1 |
| Chad Kolton | 17.2 | 0 | 1 |
| Chartered Institute of Public Relations | 17.2 | 0 | 1 |
| Cindy Rakowitz | 17.2 | 0 | 1 |
| Cirkle | 17.2 | 0 | 1 |
| Come You Are Safe, We Are from the Bombs | 17.2 | 0 | 1 |
| Contingency theory of accommodation | 17.2 | 0 | 1 |
| Corporate pathos | 17.2 | 0 | 1 |
| Creative Response Concepts | 17.2 | 0 | 1 |
| cycling in Auckland | 17.2 | 0 | 1 |
| D. K. Aruna | 17.2 | 0 | 1 |
| DCI Group | 17.2 | 0 | 1 |
| Defense Information Systems Agency | 17.2 | 0 | 1 |
| Department of Information and Public Relations | 17.2 | 0 | 1 |
| Don Knowlton | 17.2 | 0 | 1 |
| Donna Independent School District | 17.2 | 0 | 1 |
| Ducky Pond | 17.2 | 0 | 1 |
| Earl Newsom | 17.2 | 0 | 1 |
| Edward Howard | 17.2 | 0 | 1 |
| Effective Public Relations | 17.2 | 0 | 1 |
| Eleanor Legge-Bourke | 17.2 | 0 | 1 |
| English Collective of Prostitutes | 17.2 | 0 | 1 |
| Eric Mower and Associates | 17.2 | 0 | 1 |
| Q5387477 | 17.2 | 0 | 1 |
| Erick Martínez Ávila | 17.2 | 0 | 1 |
| Erin Kaplan | 17.2 | 0 | 1 |
| European Public Relations Education and Research Association | 17.2 | 0 | 1 |
| Evia Oyj | 17.2 | 0 | 1 |
| Excellence theory | 17.2 | 0 | 1 |
| FBC Media | 17.2 | 0 | 1 |
| Farah Pandith | 17.2 | 0 | 1 |
| Florida Public Relations Association | 17.2 | 0 | 1 |
| Focus on the Global South | 17.2 | 0 | 1 |
| Forsman & Bodenfors | 17.2 | 0 | 1 |
| Fraser P. Seitel | 17.2 | 0 | 1 |
| Frederic Mullally | 17.2 | 0 | 1 |
| Fujizuka | 17.2 | 0 | 1 |
| Q5546136 | 17.2 | 0 | 1 |
| Georgia Department of Education | 17.2 | 0 | 1 |
| Glenn Inwood | 17.2 | 0 | 1 |
| GlobeNewswire | 17.2 | 0 | 1 |
| Matt Bishop | 17.2 | 0 | 1 |
| Gordon Reece | 17.2 | 0 | 1 |
| Grayling | 17.2 | 0 | 1 |
| Visit Philadelphia | 17.2 | 0 | 1 |
| Greg Sharko | 17.2 | 0 | 1 |
| Worshipful Company of Communicators | 17.2 | 0 | 1 |
| Hayward Medical Communications | 17.2 | 0 | 1 |
| Hearts and minds | 17.2 | 0 | 1 |
| Hill Holliday | 17.2 | 0 | 1 |
| Howard J. Rubenstein | 17.2 | 0 | 1 |
| Howard Wolfson | 17.2 | 0 | 1 |
| Lennart Lindegren | 17.2 | 0 | 1 |
| ID public relations | 17.2 | 0 | 1 |
| ISPR Bangladesh | 17.2 | 0 | 1 |
| Information Council on the Environment | 17.2 | 0 | 1 |
| Inter-Services Public Relations | 17.2 | 0 | 1 |
| International Scientific Communications | 17.2 | 0 | 1 |
| Jacek Prześluga | 17.2 | 0 | 1 |
| James Alexander Cowan | 17.2 | 0 | 1 |
| Jane Stewart | 17.2 | 0 | 1 |
| Jeffrey Montgomery | 17.2 | 0 | 1 |
| Template:Cite press release | 17.2 | 0 | 1 |
| John Mapes | 17.2 | 0 | 1 |
| John O. Colvin | 17.2 | 0 | 1 |
| John W. Hill | 17.2 | 0 | 1 |
| Journal of Public Relations Research | 17.2 | 0 | 1 |
| Judi Lines | 17.2 | 0 | 1 |
| Judy Smith | 17.2 | 0 | 1 |
| Katherine Rothman | 17.2 | 0 | 1 |
| Ken Sunshine | 17.2 | 0 | 1 |
| Kermit Gosnell | 17.2 | 0 | 1 |
| Kevin Madden | 17.2 | 0 | 1 |
| Konstantin Lapshin | 17.2 | 0 | 1 |
| Kyodo Public Relations | 17.2 | 0 | 1 |
| Heike Ströle-Bühler | 17.2 | 0 | 1 |
| Lake Dallas Independent School District | 17.2 | 0 | 1 |
| Larry Weber | 17.2 | 0 | 1 |
| Lauren "Deac" Lyman | 17.2 | 0 | 1 |
| Lee Remmel | 17.2 | 0 | 1 |
| list of public relations journals | 17.2 | 0 | 1 |
| Luís Paixão Martins | 17.2 | 0 | 1 |
| MF Dow Jones News | 17.2 | 0 | 1 |
| MHP Communications | 17.2 | 0 | 1 |
| MSI Reproductive Choices | 17.2 | 0 | 1 |
| Marisara Pont Marchese | 17.2 | 0 | 1 |
| Marketwire | 17.2 | 0 | 1 |
| Marty Appel | 17.2 | 0 | 1 |
| Medical Communications for Combat Casualty Care | 17.2 | 0 | 1 |
| Michael Cole | 17.2 | 0 | 1 |
| Michigan Aeronautical Research Center | 17.2 | 0 | 1 |
| Microsoft joke | 17.2 | 0 | 1 |
| Middle East Public Relations Association | 17.2 | 0 | 1 |
| Modernista! | 17.2 | 0 | 1 |
| MullenLowe | 17.2 | 0 | 1 |
| NATO Communications and Information Agency | 17.2 | 0 | 1 |
| NKPR Inc | 17.2 | 0 | 1 |
| Natural Resources Conservation Service | 17.2 | 0 | 1 |
| Navy Office of Information West | 17.2 | 0 | 1 |
| New America | 17.2 | 0 | 1 |
| Category:Public relations | 17.2 | 0 | 1 |
| Rani Rahav | 17.2 | 0 | 1 |
| No. 7644 Squadron RAF | 17.2 | 0 | 1 |
| Nordic Choir | 17.2 | 0 | 1 |
| outline of public relations | 17.2 | 0 | 1 |
| PS Communication | 17.2 | 0 | 1 |
| Parker and Lee | 17.2 | 0 | 1 |
| Pentagon rapid response operation | 17.2 | 0 | 1 |
| Peter Barron | 17.2 | 0 | 1 |
| Peter Hargitay | 17.2 | 0 | 1 |
| Philip Merrill College of Journalism | 17.2 | 0 | 1 |
| Phoebe Wall Howard | 17.2 | 0 | 1 |
| Porter Novelli | 17.2 | 0 | 1 |
| Portland Communications | 17.2 | 0 | 1 |
| Pressparty | 17.2 | 0 | 1 |
| Public Communications Inc. | 17.2 | 0 | 1 |
| Public Relations | 17.2 | 0 | 1 |
| Public Relations | 17.2 | 0 | 1 |
| Public Relations Consultants Association | 17.2 | 0 | 1 |
| Public Relations Exercise | 17.2 | 0 | 1 |
| Public Relations Institute of Australia | 17.2 | 0 | 1 |
| Public Relations Society of America | 17.2 | 0 | 1 |
| Public relations | 17.2 | 0 | 1 |
| Public relations in India | 17.2 | 0 | 1 |
| Public relations of The Church of Jesus Christ of Latter-day Saints | 17.2 | 0 | 1 |
| Public relations of high fructose corn syrup | 17.2 | 0 | 1 |
| Real Ting | 17.2 | 0 | 1 |
| Quarry Integrated Communications | 17.2 | 0 | 1 |
| R&R Partners | 17.2 | 0 | 1 |
| Rachel Whetstone | 17.2 | 0 | 1 |
| Rendon Group | 17.2 | 0 | 1 |
| research strategies of election campaign communication research | 17.2 | 0 | 1 |
| Richard Fitzwilliams | 17.2 | 0 | 1 |
| Richard Weiner | 17.2 | 0 | 1 |
| Robert M. Miller | 17.2 | 0 | 1 |
| Robert Mullen Company | 17.2 | 0 | 1 |
| Robert T. Hastings, Jr. | 17.2 | 0 | 1 |
| Ronn Torossian | 17.2 | 0 | 1 |
| Category:Public relations terminology | 17.2 | 0 | 1 |
| Sanchita Bhattacharya | 17.2 | 0 | 1 |
| Simon Lewis | 17.2 | 0 | 1 |
| Sitrick and Company | 17.2 | 0 | 1 |
| Spelman College | 17.2 | 0 | 1 |
| Staple Design | 17.2 | 0 | 1 |
| Stephen Toulouse | 17.2 | 0 | 1 |
| Steve Rubel | 17.2 | 0 | 1 |
| Stuart Higgins | 17.2 | 0 | 1 |
| Category:Wikipedia press releases | 17.2 | 0 | 1 |
| Taliban propaganda | 17.2 | 0 | 1 |
| Tex McCrary | 17.2 | 0 | 1 |
| The Broadway League | 17.2 | 0 | 1 |
| The Hoffman Agency | 17.2 | 0 | 1 |
| Thomas Bourgin | 17.2 | 0 | 1 |
| Tim Allan | 17.2 | 0 | 1 |
| Toby O'Brien | 17.2 | 0 | 1 |
| Q7851056 | 17.2 | 0 | 1 |
| Turtledove Clemens | 17.2 | 0 | 1 |
| University of International and Public Relations Prague | 17.2 | 0 | 1 |
| WHCA Roadrunner | 17.2 | 0 | 1 |
| Waldorf Statement | 17.2 | 0 | 1 |
| Walter Hayes | 17.2 | 0 | 1 |
| Q7967142 | 17.2 | 0 | 1 |
| World Television | 17.2 | 0 | 1 |
| Zachery Kouwe | 17.2 | 0 | 1 |
| Category:American public relations people | 17.2 | 0 | 1 |
| Category:Australian public relations people | 17.2 | 0 | 1 |
| Category:Austrian public relations people | 17.2 | 0 | 1 |
| Category:British public relations people | 17.2 | 0 | 1 |
| Category:Canadian public relations people | 17.2 | 0 | 1 |
| Category:English public relations people | 17.2 | 0 | 1 |
| Category:German public relations people | 17.2 | 0 | 1 |
| Category:Irish public relations people | 17.2 | 0 | 1 |
| Category:Kenyan public relations people | 17.2 | 0 | 1 |
| Category:Kyrgyzstani public relations people | 17.2 | 0 | 1 |
| Category:Romanian public relations people | 17.2 | 0 | 1 |
| Category:Russian public relations people | 17.2 | 0 | 1 |
| Category:Scottish public relations people | 17.2 | 0 | 1 |
| Category:Press release agencies | 17.2 | 0 | 1 |
| Category:Public relations companies of Canada | 17.2 | 0 | 1 |
| Category:Public relations companies | 17.2 | 0 | 1 |
| Category:Public relations companies of the United States | 17.2 | 0 | 1 |
| Category:Public relations companies of the United Kingdom | 17.2 | 0 | 1 |
| Category:Public relations in the United States | 17.2 | 0 | 1 |
| Category:Public relations techniques | 17.2 | 0 | 1 |
| Category:Public relations theorists | 17.2 | 0 | 1 |
| Category:Sri Lankan public relations people | 17.2 | 0 | 1 |
| Category:Swedish public relations people | 17.2 | 0 | 1 |
| Category:Works about public relations | 17.2 | 0 | 1 |
| Category:Media relations | 17.2 | 0 | 1 |
| Public Relations Student Society of America | 17.2 | 0 | 1 |
| Federal Statistical System of the United States | 17.2 | 0 | 1 |
| Category:Public relations people | 17.2 | 0 | 1 |
| Category:Public relations executives | 17.2 | 0 | 1 |
| marketing for educational institutions | 17.2 | 0 | 1 |
| AMI Communications | 17.2 | 0 | 1 |
| AKMU | 17.2 | 0 | 1 |
| Wikipedia:Press releases | 17.2 | 0 | 1 |
| Black+Decker | 17.2 | 0 | 1 |
| Vivian Wing-Wah Yam | 17.2 | 0 | 1 |
| Jawed Ludin | 17.2 | 0 | 1 |
| Japan Racing Public Relations Center | 17.2 | 0 | 1 |
| Inoue Public Relations | 17.2 | 0 | 1 |
| Takashi Inoue | 17.2 | 0 | 1 |
| Cabinet Public Relations Secretary | 17.2 | 0 | 1 |
| Land, Infrastructure and Transport (Public Relations Magazine) | 17.2 | 0 | 1 |
| government public relations | 17.2 | 0 | 1 |
| Public Relations Society Of Japan | 17.2 | 0 | 1 |
| Japan Maritime Public Relations Center | 17.2 | 0 | 1 |
| TEPCO Public Relations | 17.2 | 0 | 1 |
| Shirakabe Barracks | 17.2 | 0 | 1 |
| Dentsu Public Relations | 17.2 | 0 | 1 |
| Jacek Łęski | 17.2 | 0 | 1 |
| Q11742432 | 17.2 | 0 | 1 |
| newswire | 17.2 | 0 | 1 |
| Press | 17.2 | 0 | 1 |
| Dagmar | 17.2 | 0 | 1 |
| organisational communication and public relations | 17.2 | 0 | 1 |
| Sidsel Dalen | 17.2 | 0 | 1 |
| Green PR | 17.2 | 0 | 1 |
| Cand.Scient.Soc. | 17.2 | 0 | 1 |
| René la Cour Sell | 17.2 | 0 | 1 |
| Kaja Tampere | 17.2 | 0 | 1 |
| Army Public Relations Service | 17.2 | 0 | 1 |
| E-PR | 17.2 | 0 | 1 |
| Korea Public Relations Consultancy Association | 17.2 | 0 | 1 |
| Korea Communications Agency | 17.2 | 0 | 1 |
| spin | 17.2 | 0 | 1 |
| Q12815709 | 17.2 | 0 | 1 |
| Frank Luntz | 17.2 | 0 | 1 |
| Public Relations Department of Thailand | 17.2 | 0 | 1 |
| Director of Public Relations and Psychological Warfare of the Myanmar Army | 17.2 | 0 | 1 |
| Category:Historians of public relations | 17.2 | 0 | 1 |
| Category:Pakistani public relations people | 17.2 | 0 | 1 |
| Category:Public relations by country | 17.2 | 0 | 1 |
| Category:Public relations in the United Kingdom | 17.2 | 0 | 1 |
| Category:Public relations people by nationality | 17.2 | 0 | 1 |
| Category:Public relations pioneers | 17.2 | 0 | 1 |
| Wikipedia publishes 500,000 articles in 50 languages | 17.2 | 0 | 1 |
| Kate Garvey | 17.2 | 0 | 1 |
| Template:Cleanup-PR | 17.2 | 0 | 1 |
| Haskell Cohen | 17.2 | 0 | 1 |
| Dragon Ball | 17.2 | 0 | 1 |
| Mélanie Joly | 17.2 | 0 | 1 |
| Public Relations | 17.2 | 0 | 1 |
| Category:Inter-Services Public Relations films | 17.2 | 0 | 1 |
| Category:Non-fiction books about public relations | 17.2 | 0 | 1 |
| Category:Novels about public relations | 17.2 | 0 | 1 |
| Category:Public relations companies based in Washington, D.C. | 17.2 | 0 | 1 |
| Category:Public relations people by role | 17.2 | 0 | 1 |
| Category:Belarusian public relations people | 17.2 | 0 | 1 |
| Herbert Schmertz | 17.2 | 0 | 1 |
| Moungi Bawendi | 17.2 | 0 | 1 |
| Wikipedia:Press releases/February 2004 | 17.2 | 0 | 1 |
| Public Relations Consultants Association of India | 17.2 | 0 | 1 |
| D-Wave Two | 17.2 | 0 | 1 |
| Template:Press release section | 17.2 | 0 | 1 |
| European Journal of Palliative Care | 17.2 | 0 | 1 |
| Clinical Evidence | 17.2 | 0 | 1 |
| International Public Relations Review | 17.2 | 0 | 1 |
| Aktualnosci Neurologiczne | 17.2 | 0 | 1 |
| Journal of Hospital Marketing and Public Relations | 17.2 | 0 | 1 |
| Q15820304 | 17.2 | 0 | 1 |
| Steffen-Peter Ballstaedt | 17.2 | 0 | 1 |
| Police Public Relations Branch | 17.2 | 0 | 1 |
| Poynter Institute | 17.2 | 0 | 1 |
| Public Relations Global Network | 17.2 | 0 | 1 |
| Beulah Livingstone | 17.2 | 0 | 1 |
| Betsy Plank | 17.2 | 0 | 1 |
| Bob Leaf | 17.2 | 0 | 1 |
| Jack Geraghty | 17.2 | 0 | 1 |
| Nick Hewer | 17.2 | 0 | 1 |
| Q16107329 | 17.2 | 0 | 1 |
| Tom Horner | 17.2 | 0 | 1 |
| Korean Academic Society for Public Relations | 17.2 | 0 | 1 |
| Korean Association for Advertising and Public Relations | 17.2 | 0 | 1 |
| Kim McKay | 17.2 | 0 | 1 |
| Hasina Momtaz | 17.2 | 0 | 1 |
| Robert H. Socolow | 17.2 | 0 | 1 |
| Molly Contogeorge | 17.2 | 0 | 1 |
| Diego Rossi | 17.2 | 0 | 1 |
| Government public relations | 17.2 | 0 | 1 |
| Rembrandt Flores | 17.2 | 0 | 1 |
| Category:Moroccan public relations people | 17.2 | 0 | 1 |
| Category:Ukrainian public relations people | 17.2 | 0 | 1 |
| Jim Haynes | 17.2 | 0 | 1 |
| Hong Kong Government Press Releases | 17.2 | 0 | 1 |
| Public relations campaigns of Edward Bernays | 17.2 | 0 | 1 |
| Australian Army Public Relations Service | 17.2 | 0 | 1 |
| Mena Media Consulting | 17.2 | 0 | 1 |
| John Cotton Dana Award | 17.2 | 0 | 1 |
| Bruce Bonafede | 17.2 | 0 | 1 |
| Public Relations Consultants Association v Newspaper Licensing Agency Ltd | 17.2 | 0 | 1 |
| Barcelona Principles | 17.2 | 0 | 1 |
| Mountain Meadows massacre and Mormon public relations | 17.2 | 0 | 1 |
| Global Strategy Group | 17.2 | 0 | 1 |
| Roger Salazar | 17.2 | 0 | 1 |
| Westbourne Communications | 17.2 | 0 | 1 |
| Ministry of Public Relations and Public Affairs | 17.2 | 0 | 1 |
| Olmstead Williams Communications | 17.2 | 0 | 1 |
| Terrie Williams | 17.2 | 0 | 1 |
| public relations | 17.2 | 0 | 1 |
| Belinda Wilkes | 17.2 | 0 | 1 |
| Angelica Pegani | 17.2 | 0 | 1 |
| Arnie Patterson | 17.2 | 0 | 1 |
| Bill Harlow | 17.2 | 0 | 1 |
| Jim Leslie | 17.2 | 0 | 1 |
| Q17489597 | 17.2 | 0 | 1 |
| GAO reveals $1.6 billion spent on public relations by the Bush administration in 2003-2005 | 17.2 | 0 | 1 |
| Bush's Iraq 'Strategy' seen as public relations exercise | 17.2 | 0 | 1 |
| U.S. federal communications agency revisits do-not-call registry | 17.2 | 0 | 1 |
| US Highway Administration releases interim report on Boston's Big Dig: press release claims tunnel safe, but report does not | 17.2 | 0 | 1 |
| Q17922010 | 17.2 | 0 | 1 |
| Q17971383 | 17.2 | 0 | 1 |
| CommCore Consulting Group | 17.2 | 0 | 1 |
| Caroline Eriksson | 17.2 | 0 | 1 |
| Prain Global | 17.2 | 0 | 1 |
| Fujitsu ScanSnap | 17.2 | 0 | 1 |
| Mokgweetsi Masisi | 17.2 | 0 | 1 |
| Template:Wikimedia Polska press release | 17.2 | 0 | 1 |
| Q18679608 | 17.2 | 0 | 1 |
| LM Someco | 17.2 | 0 | 1 |
| Miltton | 17.2 | 0 | 1 |
| Category:Swiss public relations people | 17.2 | 0 | 1 |
| Simon Huck | 17.2 | 0 | 1 |
| Susan Feeney | 17.2 | 0 | 1 |
| Unanswered Questions | 17.2 | 0 | 1 |
| Scooter Libby Indictment Press Release | 17.2 | 0 | 1 |
| Press Release concerning Great Seal of the Irish Free State | 17.2 | 0 | 1 |
| Press Release Regarding Charges Filed Against Lon Horiuchi | 17.2 | 0 | 1 |
| Press Release: FBI Announces Contract Award for Next Generation Identification System | 17.2 | 0 | 1 |
| Irish Free State press release on Statute of Westminster | 17.2 | 0 | 1 |
| Office of Special Counsel Press Release 10.18.2001 | 17.2 | 0 | 1 |
| Human Rights: Public Relations and Private Agendas - 8th January 2008 | 17.2 | 0 | 1 |
| Rep. Debbie Wasserman Schultz, Sandra Fluke and Dr. Avis Jones-DeWeever at Norton's Women’s History Month Forum on Tuesday | 17.2 | 0 | 1 |
| White House Press Releases:March 17 2005 | 17.2 | 0 | 1 |
| The Matriarch Agency | 17.2 | 0 | 1 |
| Q19661360 | 17.2 | 0 | 1 |
| Rory Sutherland | 17.2 | 0 | 1 |
| LSPR Institute of Communication and Business | 17.2 | 0 | 1 |
| Air Force Communications Agency | 17.2 | 0 | 1 |
| Sling TV | 17.2 | 0 | 1 |
| Q20182835 | 17.2 | 0 | 1 |
| Black House Media | 17.2 | 0 | 1 |
| János Makkai | 17.2 | 0 | 1 |
| DKC | 17.2 | 0 | 1 |
| Gina Din | 17.2 | 0 | 1 |
| Commonground/MGS | 17.2 | 0 | 1 |
| Terry Swartzberg | 17.2 | 0 | 1 |
| József Ferling | 17.2 | 0 | 1 |
| Self-Portrait with Palette | 17.2 | 0 | 1 |
| China: Through the Looking Glass | 17.2 | 0 | 1 |
| Isabel Ruiz | 17.2 | 0 | 1 |
| Jack Leslie | 17.2 | 0 | 1 |
| Jeremy Whitley | 17.2 | 0 | 1 |
| Laurence Moskowitz | 17.2 | 0 | 1 |
| Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved | 17.2 | 0 | 1 |
| Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study | 17.2 | 0 | 1 |
| Using Clinical Evidence in a national continuing medical education program in Italy | 17.2 | 0 | 1 |
| Kelly Piquet | 17.2 | 0 | 1 |
| Eric White | 17.2 | 0 | 1 |
| William Stewart McPhee Howard | 17.2 | 0 | 1 |
| Inez Y. Kaiser | 17.2 | 0 | 1 |
| John Murray, 9th Earl of Dunmore | 17.2 | 0 | 1 |
| Librarian of Congress Adds 25 Films to National Film Registry | 17.2 | 0 | 1 |
| Female genital mutilation and infections: a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| Template:Cite press release/new | 17.2 | 0 | 1 |
| domain authority | 17.2 | 0 | 1 |
| Fionnuala Kenny | 17.2 | 0 | 1 |
| IPRA Golden World Awards | 17.2 | 0 | 1 |
| Gert von Klass | 17.2 | 0 | 1 |
| Eliana Benador | 17.2 | 0 | 1 |
| Albert John (Bert) Felan | 17.2 | 0 | 1 |
| Nazanin Zaghari-Ratcliffe | 17.2 | 0 | 1 |
| Michels Warren | 17.2 | 0 | 1 |
| PRODUCTION ON “PETE’S DRAGON” BEGINS IN NEW ZEALAND, STARRING BRYCE DALLAS HOWARD, OAKES FEGLEY AS PETE AND ROBERT REDFORD | 17.2 | 0 | 1 |
| David Ian Campbell | 17.2 | 0 | 1 |
| Beauty and the Beast Project Profile | 17.2 | 0 | 1 |
| Zootopia Press Kit | 17.2 | 0 | 1 |
| WALT DISNEY ANIMATION STUDIOS SETS SAIL WITH “MOANA” | 17.2 | 0 | 1 |
| Inner Workings & Moana | 17.2 | 0 | 1 |
| INNER WORKINGS Project Profile | 17.2 | 0 | 1 |
| Moana Project Profile | 17.2 | 0 | 1 |
| ‘Descendants 2’ Greenlit | 17.2 | 0 | 1 |
| The scientific credibility of Freud's theories and therapy | 17.2 | 0 | 1 |
| Scientists and the marketplace of opinions. Scientific credibility takes on a different meaning when reaching out to the public | 17.2 | 0 | 1 |
| Disney/Pixar’s Finding Dory to dive into theaters November 25, 2015 | 17.2 | 0 | 1 |
| Constructing “Sound Science” and “Good Epidemiology”: Tobacco, Lawyers, and Public Relations Firms | 17.2 | 0 | 1 |
| Finding Dory Press Kit | 17.2 | 0 | 1 |
| Desmopressin in the treatment of nocturia: clinical evidence and experience | 17.2 | 0 | 1 |
| Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence | 17.2 | 0 | 1 |
| The Finest Hours Press Kit | 17.2 | 0 | 1 |
| The BFG Press Kit | 17.2 | 0 | 1 |
| Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence | 17.2 | 0 | 1 |
| Clinical evidence of blood transfusion effectiveness | 17.2 | 0 | 1 |
| The Jungle Book Press Kit | 17.2 | 0 | 1 |
| The Jungle Book Project Profile | 17.2 | 0 | 1 |
| The BFG Project Profile | 17.2 | 0 | 1 |
| Alice Through the Looking Glass Press Kit | 17.2 | 0 | 1 |
| Clinical Evidence: a useful tool for promoting evidence-based practice? | 17.2 | 0 | 1 |
| The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ). | 17.2 | 0 | 1 |
| Hope Hicks | 17.2 | 0 | 1 |
| Dialogic public relations theory | 17.2 | 0 | 1 |
| Barnet & Reef Associates | 17.2 | 0 | 1 |
| Category:Public relations in the Philippines | 17.2 | 0 | 1 |
| Category:Filipino public relations people | 17.2 | 0 | 1 |
| Baptist Health South Florida | 17.2 | 0 | 1 |
| Category:Dutch public relations people | 17.2 | 0 | 1 |
| DiGennaro Communications | 17.2 | 0 | 1 |
| Category:Public relations companies in West Virginia | 17.2 | 0 | 1 |
| Sequel to ‘Wreck-It Ralph’ Hits Theaters on March 9, 2018 | 17.2 | 0 | 1 |
| James Morrissey | 17.2 | 0 | 1 |
| Barbara Charone | 17.2 | 0 | 1 |
| Navy Public Relations Service | 17.2 | 0 | 1 |
| Kärt Einlo | 17.2 | 0 | 1 |
| Captain America: Civil War Press Kit | 17.2 | 0 | 1 |
| Q26106298 | 17.2 | 0 | 1 |
| Szilvia Magony | 17.2 | 0 | 1 |
| The Old Church Tower at Nuenen | 17.2 | 0 | 1 |
| Kajar Kase | 17.2 | 0 | 1 |
| Queen of Katwe Press Kit | 17.2 | 0 | 1 |
| Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence | 17.2 | 0 | 1 |
| Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence | 17.2 | 0 | 1 |
| Brachial-Ankle Pulse Wave Velocity: Background, Method, and Clinical Evidence | 17.2 | 0 | 1 |
| Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience | 17.2 | 0 | 1 |
| Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence | 17.2 | 0 | 1 |
| Level of clinical evidence presented at the International Society for Hip Arthroscopy Annual Scientific Meeting over 5 years (2010-2014) | 17.2 | 0 | 1 |
| Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence | 17.2 | 0 | 1 |
| The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence | 17.2 | 0 | 1 |
| Early versus late tracheostomy for critically ill patients: A clinical evidence synopsis of a recent Cochrane Review | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence | 17.2 | 0 | 1 |
| Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence | 17.2 | 0 | 1 |
| Thrombus aspiration during primary percutaneous coronary intervention for acute myocardial infarction: A review of clinical evidence and guidelines | 17.2 | 0 | 1 |
| Pancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence Review | 17.2 | 0 | 1 |
| Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks | 17.2 | 0 | 1 |
| Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials | 17.2 | 0 | 1 |
| Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence | 17.2 | 0 | 1 |
| Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments | 17.2 | 0 | 1 |
| Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications | 17.2 | 0 | 1 |
| Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence | 17.2 | 0 | 1 |
| Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer | 17.2 | 0 | 1 |
| Adipose-Derived Mesenchymal Stem Cells for the Treatment of Articular Cartilage: A Systematic Review on Preclinical and Clinical Evidence | 17.2 | 0 | 1 |
| Review of the powder and decoction formulae in Traditional Chinese Medicine based on pharmacologically active substances and clinical evidence | 17.2 | 0 | 1 |
| Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence | 17.2 | 0 | 1 |
| A Review of Nebivolol Pharmacology and Clinical Evidence | 17.2 | 0 | 1 |
| Confronting diversity in the production of clinical evidence goes beyond merely including under-represented groups in clinical trials | 17.2 | 0 | 1 |
| Ticagrelor: molecular discovery to clinical evidence: ticagrelor: a novel antiplatelet agent | 17.2 | 0 | 1 |
| Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application | 17.2 | 0 | 1 |
| Journal of Ultrasonography : official publication of Polish Ultrasound Society / Red. nacz. Iwona Sudoł-Szopińska | 17.2 | 0 | 1 |
| N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence | 17.2 | 0 | 1 |
| The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence | 17.2 | 0 | 1 |
| Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses | 17.2 | 0 | 1 |
| Vascular disturbances in primary aldosteronism: clinical evidence | 17.2 | 0 | 1 |
| THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues | 17.2 | 0 | 1 |
| Dairy Foods and Dairy Proteins in the Management of Type 2 Diabetes: A Systematic Review of the Clinical Evidence | 17.2 | 0 | 1 |
| Deep venous thrombosis in children with musculoskeletal infections: the clinical evidence | 17.2 | 0 | 1 |
| Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage | 17.2 | 0 | 1 |
| First Look at Disney Channel’s “Descendants 2” | 17.2 | 0 | 1 |
| Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer | 17.2 | 0 | 1 |
| Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence | 17.2 | 0 | 1 |
| Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence | 17.2 | 0 | 1 |
| RAAS inhibition and mortality in hypertension: from pharmacology to clinical evidence | 17.2 | 0 | 1 |
| Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance | 17.2 | 0 | 1 |
| The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms | 17.2 | 0 | 1 |
| GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence | 17.2 | 0 | 1 |
| Endobronchial Valves in Treatment of Persistent Air Leaks: A Systematic Review of Clinical Evidence | 17.2 | 0 | 1 |
| Disney and Jon Favreau Joining Forces on “The Lion King” | 17.2 | 0 | 1 |
| Ant-Man Press Kit | 17.2 | 0 | 1 |
| Katie Perrior | 17.2 | 0 | 1 |
| Current Clinical Evidence on the Effect of General Anesthesia on Neurodevelopment in Children: An Updated Systematic Review with Meta-Regression | 17.2 | 0 | 1 |
| 1971: Beyond Borders | 17.2 | 0 | 1 |
| National Conference on Dental Public Relations | 17.2 | 0 | 1 |
| The Public relations journal | 17.2 | 0 | 1 |
| Profiles in healthcare communications | 17.2 | 0 | 1 |
| Race to Witch Mountain Press Kit | 17.2 | 0 | 1 |
| Department of Information & Public Relations, Himachal Pradesh | 17.2 | 0 | 1 |
| Jerry Voros | 17.2 | 0 | 1 |
| DISNEY'S LIVE ACTION "CINDERELLA" BEGINS PRINCIPAL PHOTOGRAPHY IN LONDON | 17.2 | 0 | 1 |
| Cinderella Press Kit | 17.2 | 0 | 1 |
| “Mary Poppins Returns” Sequel Announced for December 2018 | 17.2 | 0 | 1 |
| Moana Press Kit | 17.2 | 0 | 1 |
| James Chapman | 17.2 | 0 | 1 |
| Dr Michael Kelly, b. 1940. Public relations consultant, Lord Provost of Glasgow 1980 - 1984 | 17.2 | 0 | 1 |
| Rogue One: A Star Wars Story Press Kit | 17.2 | 0 | 1 |
| McFarland, USA Press Kit | 17.2 | 0 | 1 |
| Q28053300 | 17.2 | 0 | 1 |
| The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence | 17.2 | 0 | 1 |
| The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use | 17.2 | 0 | 1 |
| Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience | 17.2 | 0 | 1 |
| Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence? | 17.2 | 0 | 1 |
| Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence | 17.2 | 0 | 1 |
| What type of clinical evidence is needed to assess medical devices? | 17.2 | 0 | 1 |
| Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence | 17.2 | 0 | 1 |
| The biology and clinical evidence of microfracture in hip preservation surgery | 17.2 | 0 | 1 |
| Hypoxia after stroke: a review of experimental and clinical evidence | 17.2 | 0 | 1 |
| Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists | 17.2 | 0 | 1 |
| Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence | 17.2 | 0 | 1 |
| A Valuable Option for the Treatment of Respiratory Diseases: Review on the Clinical Evidence of the Ivy Leaves Dry Extract EA 575® | 17.2 | 0 | 1 |
| Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence | 17.2 | 0 | 1 |
| Prospective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures | 17.2 | 0 | 1 |
| Meditation and coronary heart disease: a review of the current clinical evidence | 17.2 | 0 | 1 |
| Shabnam Asthana | 17.2 | 0 | 1 |
| Clinical evidence of an interaction between imipramine and acetylsalicylic acid on protein binding in depressed patients | 17.2 | 0 | 1 |
| Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors | 17.2 | 0 | 1 |
| Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib | 17.2 | 0 | 1 |
| Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications | 17.2 | 0 | 1 |
| Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease | 17.2 | 0 | 1 |
| Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment | 17.2 | 0 | 1 |
| Atelectasis as a cause of postoperative fever: where is the clinical evidence? | 17.2 | 0 | 1 |
| Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| Strain counterstrain: current concepts and clinical evidence | 17.2 | 0 | 1 |
| Whole Food versus Supplement: Comparing the Clinical Evidence of Tomato Intake and Lycopene Supplementation on Cardiovascular Risk Factors | 17.2 | 0 | 1 |
| Clinical evidence of the minimal androgenic activity of norgestimate | 17.2 | 0 | 1 |
| Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action | 17.2 | 0 | 1 |
| Frankie Byrne | 17.2 | 0 | 1 |
| Extracts from "Clinical evidence": Athlete's foot and fungally infected toenails | 17.2 | 0 | 1 |
| Aberration of FHIT Gene is Associated with Increased Tumor Proliferation and Decreased Apoptosis—Clinical Evidence in Lung and Head and Neck Carcinomas | 17.2 | 0 | 1 |
| Does loxapine have "atypical" properties? Clinical evidence | 17.2 | 0 | 1 |
| Beryllium's public relations problem: protecting workers when there is no safe exposure level | 17.2 | 0 | 1 |
| Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models | 17.2 | 0 | 1 |
| Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence | 17.2 | 0 | 1 |
| Category:Directors-general of the Inter-Services Public Relations | 17.2 | 0 | 1 |
| Category:Indian public relations people | 17.2 | 0 | 1 |
| Category:Inter-Services Public Relations | 17.2 | 0 | 1 |
| Quality of pharmaceutical industry press releases based on original research | 17.2 | 0 | 1 |
| Category:Press releases | 17.2 | 0 | 1 |
| Biologic enhancement of spinal fusion with bone morphogenetic proteins: current position based on clinical evidence and future perspective | 17.2 | 0 | 1 |
| Exaggerations and Caveats in Press Releases and Health-Related Science News | 17.2 | 0 | 1 |
| The association between exaggeration in health related science news and academic press releases: retrospective observational study | 17.2 | 0 | 1 |
| Q28674029 | 17.2 | 0 | 1 |
| Arsul Sani | 17.2 | 0 | 1 |
| Of guerillas and cafés | 17.2 | 0 | 1 |
| Beauty and the Beast Press Kit | 17.2 | 0 | 1 |
| Marian Izaguirre | 17.2 | 0 | 1 |
| Accredited in Public Relations | 17.2 | 0 | 1 |
| Oram Group | 17.2 | 0 | 1 |
| Institute for Public Relations | 17.2 | 0 | 1 |
| Pendleton Dudley | 17.2 | 0 | 1 |
| Born In China Press Kit | 17.2 | 0 | 1 |
| A Test of the Third-Person Effect in Public Relations: Application of Social Comparison Theory | 17.2 | 0 | 1 |
| Spinning climate change: Corporate and NGO public relations strategies in Canada and the United States | 17.2 | 0 | 1 |
| No.104 High Street (Wilding Civil Engineering Ltd. and Powell Public Relations) | 17.2 | 0 | 1 |
| Sony α9 | 17.2 | 0 | 1 |
| Pierpont Communications | 17.2 | 0 | 1 |
| public relations and communication activities | 17.2 | 0 | 1 |
| Karla Gower | 17.2 | 0 | 1 |
| Hubert Nachtsheim | 17.2 | 0 | 1 |
| Mass notification and crisis communications - planning, preparedness, and systems | 17.2 | 0 | 1 |
| Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence | 17.2 | 0 | 1 |
| The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer | 17.2 | 0 | 1 |
| A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence | 17.2 | 0 | 1 |
| Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence | 17.2 | 0 | 1 |
| Monster Hunter: World | 17.2 | 0 | 1 |
| Ogilvy Public Relations (United States) | 17.2 | 0 | 1 |
| New Venture Fund | 17.2 | 0 | 1 |
| American Cowboy | 17.2 | 0 | 1 |
| Accounts from the field: a public relations perspective on global AIDS/HIV. | 17.2 | 0 | 1 |
| A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease | 17.2 | 0 | 1 |
| Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence | 17.2 | 0 | 1 |
| Pandemic as a communication challenge for the governmental authorities-an overview of the governmental public relations measures for the new influenza ("swine flu"). Basic communication features | 17.2 | 0 | 1 |
| The Mediated Amplification of a Crisis: Communicating the A/H1N1 Pandemic in Press Releases and Press Coverage in Europe | 17.2 | 0 | 1 |
| From press release to news: mapping the framing of the 2009 H1N1 A influenza pandemic | 17.2 | 0 | 1 |
| The impact of cochlear implantation on cognition in older adults: a systematic review of clinical evidence | 17.2 | 0 | 1 |
| Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. | 17.2 | 0 | 1 |
| Patterns of dyspepsia in patients with no clinical evidence of organic diseases | 17.2 | 0 | 1 |
| CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA. | 17.2 | 0 | 1 |
| Mozart's terminal illness: unravelling the clinical evidence | 17.2 | 0 | 1 |
| Development and validation of COMPASS: clinical evidence of orphan medicinal products - an assessment tool | 17.2 | 0 | 1 |
| Combination of alendronate plus alfacalcidol in the treatment of osteoporosis. Rationale, preclinical data and clinical evidence | 17.2 | 0 | 1 |
| Bryan Yeubrey | 17.2 | 0 | 1 |
| N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence | 17.2 | 0 | 1 |
| Alterations of the subchondral bone in osteochondral repair – translational data and clinical evidence | 17.2 | 0 | 1 |
| Extracts from "clinical evidence": age related macular degeneration | 17.2 | 0 | 1 |
| Project Candor | 17.2 | 0 | 1 |
| The medical communications officer. A resource for data collection, quality management and medical control | 17.2 | 0 | 1 |
| Extracts from "concise clinical evidence". Commentary: treatment of diabetic retinopathy | 17.2 | 0 | 1 |
| Data breach! What's next? | 17.2 | 0 | 1 |
| The National Library of Medicine's role in improving medical communications | 17.2 | 0 | 1 |
| Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration. | 17.2 | 0 | 1 |
| Leveraging scientific credibility about Arctic sea ice trends in a polarized political environment | 17.2 | 0 | 1 |
| The Value of Extent of Resection of Glioblastomas: Clinical Evidence and Current Approach | 17.2 | 0 | 1 |
| Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence | 17.2 | 0 | 1 |
| The Cochrane Library: a resource for current reviews of clinical evidence | 17.2 | 0 | 1 |
| Q30913649 | 17.2 | 0 | 1 |
| Extracts from "concise clinical evidence". Diabetic retinopathy | 17.2 | 0 | 1 |
| Clinical evidence of subcutaneous CO2 insufflations: a systematic review | 17.2 | 0 | 1 |
| Public relations in the college medical library. | 17.2 | 0 | 1 |
| Diet and psoriasis: experimental data and clinical evidence | 17.2 | 0 | 1 |
| What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors? | 17.2 | 0 | 1 |
| Evidence standards in experimental and inferential INSDC Third Party Annotation data | 17.2 | 0 | 1 |
| Clinical evidence for tumor clonogen regeneration: interpretations of the data. | 17.2 | 0 | 1 |
| Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value | 17.2 | 0 | 1 |
| Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms | 17.2 | 0 | 1 |
| The use of visual media for better public relations in a medical library | 17.2 | 0 | 1 |
| Jonathan Gasthalter | 17.2 | 0 | 1 |
| Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy | 17.2 | 0 | 1 |
| Q31884793 | 17.2 | 0 | 1 |
| Ogilvy | 17.2 | 0 | 1 |
| Self-Organization of Blood Pressure Regulation: Clinical Evidence | 17.2 | 0 | 1 |
| Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices | 17.2 | 0 | 1 |
| Ambulance officers' use of online clinical evidence | 17.2 | 0 | 1 |
| Proton therapy in clinical practice: current clinical evidence | 17.2 | 0 | 1 |
| Current clinical evidence for proton therapy | 17.2 | 0 | 1 |
| Group differences in physician responses to handheld presentation of clinical evidence: a verbal protocol analysis | 17.2 | 0 | 1 |
| Retractions, press releases and newspaper coverage | 17.2 | 0 | 1 |
| Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial | 17.2 | 0 | 1 |
| Statins for infection and sepsis: a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer | 17.2 | 0 | 1 |
| Public relations: putting the cost puzzle together | 17.2 | 0 | 1 |
| Splenectomy and cesarean section in pregnancy complicated by acute thrombocytopenic purpura. Clinical evidence for hormone control of thorombocyte level. | 17.2 | 0 | 1 |
| Microscopic and clinical evidence for Anaplasma (Ehrlichia) phagocytophilum infection in Italian cats | 17.2 | 0 | 1 |
| Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). | 17.2 | 0 | 1 |
| Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. | 17.2 | 0 | 1 |
| Cardiac repair with adult bone marrow-derived cells: the clinical evidence | 17.2 | 0 | 1 |
| Clinical Evidence that Coagulation Activation Drives Cancer Progression - a Report of 2 Cases | 17.2 | 0 | 1 |
| What does the public think of your blood bank? Here are some sound public relations procedures | 17.2 | 0 | 1 |
| Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical Evidence. | 17.2 | 0 | 1 |
| Can green tea do that? A literature review of the clinical evidence | 17.2 | 0 | 1 |
| Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association | 17.2 | 0 | 1 |
| Clinical evidence for the pharmacological therapy in newborn infants with hypoxic-ischemic encephalopathy | 17.2 | 0 | 1 |
| American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer | 17.2 | 0 | 1 |
| Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence | 17.2 | 0 | 1 |
| Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence | 17.2 | 0 | 1 |
| Is early clinical evidence of autonomic shift predictive of infection after aneurysmal subarachnoid hemorrhage | 17.2 | 0 | 1 |
| Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms | 17.2 | 0 | 1 |
| Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence | 17.2 | 0 | 1 |
| Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants | 17.2 | 0 | 1 |
| The Impact of Osseous Malalignment and Realignment Procedures in Knee Ligament Surgery: A Systematic Review of the Clinical Evidence | 17.2 | 0 | 1 |
| Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders | 17.2 | 0 | 1 |
| Study design and clinical evidence in mRCC: can we save axitinib as a first-line therapy? | 17.2 | 0 | 1 |
| Diclofenac potassium for oral solution (CAMBIA®) in the acute management of a migraine attack: clinical evidence and practical experience | 17.2 | 0 | 1 |
| Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012. | 17.2 | 0 | 1 |
| Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis | 17.2 | 0 | 1 |
| Clinical evidence: atopic eczema | 17.2 | 0 | 1 |
| An emergency medical communications system by low altitude platform at the early stages of a natural disaster in Indonesia | 17.2 | 0 | 1 |
| Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment | 17.2 | 0 | 1 |
| Clinical evidence for heterogeneity in myotonic dystrophy | 17.2 | 0 | 1 |
| Clinical evidence: glycaemic control in diabetes | 17.2 | 0 | 1 |
| Interventions during pregnancy to reduce excessive gestational weight gain: a systematic review assessing current clinical evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system | 17.2 | 0 | 1 |
| Surgical decompression in acute spinal cord injury: A review of clinical evidence, animal model studies, and potential future directions of investigation | 17.2 | 0 | 1 |
| Review article: clinical evidence to support current therapies of irritable bowel syndrome | 17.2 | 0 | 1 |
| Medical communications: techniques and strategies | 17.2 | 0 | 1 |
| International scientific communications in the field of colorectal tumour markers | 17.2 | 0 | 1 |
| From the life-cycles of clinical evidence to the learning curve of clinical experience | 17.2 | 0 | 1 |
| Extracts from "Clinical Evidence". Malaria: prevention in travellers | 17.2 | 0 | 1 |
| "Extracts from "Clinical evidence": Menopausal symptoms | 17.2 | 0 | 1 |
| Extracts from "clinical evidence": hip fracture | 17.2 | 0 | 1 |
| Extracts from "Clinical Evidence". Obesity. | 17.2 | 0 | 1 |
| Extracts from "Clinical evidence": Bulimia nervosa | 17.2 | 0 | 1 |
| Using clinical evidence. Randomised controlled trials are not the only evidence | 17.2 | 0 | 1 |
| Extracts from "clinical evidence": Infantile colic | 17.2 | 0 | 1 |
| Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence | 17.2 | 0 | 1 |
| Hypericum for depression. An update of the clinical evidence | 17.2 | 0 | 1 |
| Extracts from the "clinical evidence". Endometriosis | 17.2 | 0 | 1 |
| Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma | 17.2 | 0 | 1 |
| The Role of HCG in Implantation: A Mini-Review of Molecular and Clinical Evidence | 17.2 | 0 | 1 |
| A red hot issue or a red herring? The scientific credibility of psychoanalysis | 17.2 | 0 | 1 |
| Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. | 17.2 | 0 | 1 |
| Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence | 17.2 | 0 | 1 |
| Infant with Clinical Evidence of Pulmonary Hypoplasia: A Case Report | 17.2 | 0 | 1 |
| The Publication Ranking Score for pediatric urology: quantifying thought leadership within the subspecialty. | 17.2 | 0 | 1 |
| An expert system for performance-based direct delivery of published clinical evidence | 17.2 | 0 | 1 |
| Clinical evidence with montelukast in the management of chronic childhood asthma | 17.2 | 0 | 1 |
| Delivering clinical evidence where it's needed: building an information system worthy of the profession. | 17.2 | 0 | 1 |
| Visualizing clinical evidence: citation networks for the incubation periods of respiratory viral infections | 17.2 | 0 | 1 |
| Clinical evidence for the adenoma-carcinoma sequence | 17.2 | 0 | 1 |
| Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. | 17.2 | 0 | 1 |
| The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine | 17.2 | 0 | 1 |
| Antibiotic treatment of gonorrhoea--clinical evidence for choice | 17.2 | 0 | 1 |
| Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications | 17.2 | 0 | 1 |
| Place of parenteral cephalosporins in the ambulatory setting: clinical evidence | 17.2 | 0 | 1 |
| Local tumor control and survival: clinical evidence and tumor biologic basis. | 17.2 | 0 | 1 |
| Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris | 17.2 | 0 | 1 |
| "Flower remedies": a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| Clinical evidence in guardianship of older adults is inadequate: findings from a tri-state study | 17.2 | 0 | 1 |
| Kombucha: a systematic review of the clinical evidence | 17.2 | 0 | 1 |
| Survey on clinical evidence of acupuncture therapy for fibromyalgia syndrome | 17.2 | 0 | 1 |
| Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. | 17.2 | 0 | 1 |
| Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers | 17.2 | 0 | 1 |
| Does clinical evidence support ICD-9-CM diagnosis coding of complications? | 17.2 | 0 | 1 |
| Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence | 17.2 | 0 | 1 |
| Pattern and quality of scientific communications on drug safety produced by a regional pharmacovigilance center in Nepal | 17.2 | 0 | 1 |
| Soybean isoflavone exposure does not have feminizing effects on men: a critical examination of the clinical evidence | 17.2 | 0 | 1 |
| The application of the glycemic index and glycemic load in weight loss: A review of the clinical evidence | 17.2 | 0 | 1 |
| Molecular and clinical evidence of Ehrlichia chaffeensis infection in Cameroonian patients with undifferentiated febrile illness | 17.2 | 0 | 1 |
| Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. | 17.2 | 0 | 1 |
| COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence | 17.2 | 0 | 1 |
| Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin. | 17.2 | 0 | 1 |
| Clinical evidence for secondary epileptogenesis | 17.2 | 0 | 1 |
| Anticonvulsants in neuropathic pain: rationale and clinical evidence | 17.2 | 0 | 1 |
| Stable angina pectoris: what does the current clinical evidence tell us? | 17.2 | 0 | 1 |
| Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy | 17.2 | 0 | 1 |
| Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence | 17.2 | 0 | 1 |
| Maintaining clinical credibility as a nurse teacher in a postgraduate tertiary specialization program | 17.2 | 0 | 1 |
| Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science | 17.2 | 0 | 1 |
| Chemotherapy sensitization by rituximab: experimental and clinical evidence. | 17.2 | 0 | 1 |
| Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence | 17.2 | 0 | 1 |
| Diet and risk of atrial fibrillation – epidemiologic and clinical evidence –. | 17.2 | 0 | 1 |
| Cognitive enhancers in the treatment of substance use disorders: Clinical evidence | 17.2 | 0 | 1 |
| Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link | 17.2 | 0 | 1 |
| Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? | 17.2 | 0 | 1 |
| Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence | 17.2 | 0 | 1 |
| Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence | 17.2 | 0 | 1 |
| Clinical Evidence: Genital herpes | 17.2 | 0 | 1 |
| Clinical Evidence: Non-metastatic prostate cancer. | 17.2 | 0 | 1 |
| Clinical Evidence: Emerging approaches in preventing cardiovascular disease. | 17.2 | 0 | 1 |
| EMLA anaesthetic cream for sharp leg ulcer debridement: a review of the clinical evidence for analgesic efficacy and tolerability | 17.2 | 0 | 1 |
| Clinical Evidence: Psychosocial factors in the etiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. | 17.2 | 0 | 1 |
| Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence | 17.2 | 0 | 1 |
| Bazedoxifene: literature data and clinical evidence | 17.2 | 0 | 1 |
| Quality care through clinical evidence--the SAPC annual scientific meeting in Birmingham. Society for Academic Primary Care | 17.2 | 0 | 1 |
| Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease | 17.2 | 0 | 1 |
| Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence | 17.2 | 0 | 1 |
| Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution | 17.2 | 0 | 1 |
| Endangerment of the brain by glucocorticoids: experimental and clinical evidence | 17.2 | 0 | 1 |
| Cost-effectiveness of Head CT in Patients With Lung Cancer Without Clinical Evidence of Metastases | 17.2 | 0 | 1 |
| Green tea and green tea catechin extracts: An overview of the clinical evidence | 17.2 | 0 | 1 |
| Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence | 17.2 | 0 | 1 |
| Safety of soy-based infant formulas containing isoflavones: the clinical evidence | 17.2 | 0 | 1 |
| Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma | 17.2 | 0 | 1 |
| Cancer chemoprevention by pomegranate: laboratory and clinical evidence | 17.2 | 0 | 1 |
| Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes | 17.2 | 0 | 1 |
| Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans | 17.2 | 0 | 1 |
| Use of incisional negative pressure wound therapy on closed median sternal incisions after cardiothoracic surgery: clinical evidence and consensus recommendations | 17.2 | 0 | 1 |
| Review of Toluene Actions: Clinical Evidence, Animal Studies, and Molecular Targets | 17.2 | 0 | 1 |
| Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock | 17.2 | 0 | 1 |
| Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. | 17.2 | 0 | 1 |
| CT imaging of myocardial viability: experimental and clinical evidence | 17.2 | 0 | 1 |
| Depression and nicotine: Preclinical and clinical evidence for common mechanisms | 17.2 | 0 | 1 |
| Clinical evidence for osteoarthritis as an inflammatory disease | 17.2 | 0 | 1 |